Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biologic characterization of the subcutaneously implanted Lewis lung tumor.

× No keyword cloud information.

17 in total

1. Total parenteral nutrition in mice bearing a metastatic carcinoma: tumor growth, metastasis and immunologic parameters.

Authors: M D Cohen; M Bryant; E M Copeland; S M Mahaffey; K J Kao; T G Baumgartner; C I Wei; H S Sitren
Journal: Clin Exp Metastasis Date: 1986 Oct-Dec Impact factor: 5.150

Review 2. Mouse models of cancer-associated thrombosis.

Authors: Yohei Hisada; Nigel Mackman
Journal: Thromb Res Date: 2017-12-29 Impact factor: 3.944

3. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.

Authors: F Aranda; N Bloy; J Pesquet; B Petit; K Chaba; A Sauvat; O Kepp; N Khadra; D Enot; C Pfirschke; M Pittet; L Zitvogel; G Kroemer; L Senovilla
Journal: Oncogene Date: 2014-07-28 Impact factor: 9.867

4. Diurnal variations of tumor growth and its influence on cytostatic treatment.

Authors: M Flentje; G Akokan; D Reinecke; H O Klein
Journal: Blut Date: 1981-08

5. Host age is a systemic regulator of gene expression impacting cancer progression.

Authors: Afshin Beheshti; Sébastien Benzekry; J Tyson McDonald; Lili Ma; Michael Peluso; Philip Hahnfeldt; Lynn Hlatky
Journal: Cancer Res Date: 2015-03-02 Impact factor: 12.701

6. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.

Authors: M C Bissery; C H Nguyen; E Bisagni; P Vrignaud; F Lavelle
Journal: Invest New Drugs Date: 1993-11 Impact factor: 3.850

Biologic characterization of the subcutaneously implanted Lewis lung tumor.

1. Total parenteral nutrition in mice bearing a metastatic carcinoma: tumor growth, metastasis and immunologic parameters.

Review 2. Mouse models of cancer-associated thrombosis.

3. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer.

4. Diurnal variations of tumor growth and its influence on cytostatic treatment.

5. Host age is a systemic regulator of gene expression impacting cancer progression.

6. Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.

7. Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cells.

8. Tumor localization of Lewis lung carcinoma with radiolabeled monoclonal antibodies.

9. Chemotherapeutic sensitivity of liver metastases from intrasplenically-growing Lewis lung tumor.

10. Antitumor activity of Ilmofosine (BM 41.440) in the 3Lewis-lung carcinoma model.